Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients
Acta Neuropathologica · 2025
DOI: 10.1007/s00401-025-02873-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2025. Verfasst von Omkar Singh und 32 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Astrocytoma, Brain Neoplasms, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A putative molecular subtype of IDH-wildtype diffuse glioma with recurrent MAPK pathway alterations has recently been reported. By dimensionality reduction analysis of genome-wide methylation profiling, these tumors form a distinct methylation cluster of gliomas. Characterization of 47 tumors from 45 patients reveals that these gliomas are predominantly supratentorial in young adults, are highly infiltrative, and harbor mitogen-activated protein kinase (MAPK) pathway alterations with high rates of CDKN2A/2B deletion, PDGFRA amplification, MYCN amplification, NF1 variants, and BRAF alterations. The tumors’ epigenetics are distinct from other adult and pediatric gliomas in the 2021 World Health Organization (WHO) classification. The histology of the gliomas most often demonstrates high-grade astrocytic features, but can be variable from tumor to tumor, as well as fall into a spectrum of histologic grades. Outcomes show considerable variability based on histologic grade and molecular features, supporting grading within this group of tumors to ensure optimal care choices on an individual patient basis. These unifying epigenetic, sequencing, and infiltrative astrocytic features allow the tumors to be considered diffuse astrocytoma, adolescent, and young adult-type, with MAPK alterations (DAYA).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
- Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
- CellNetix Laboratories, Seattle, WA, USA.
- Department of Medical Education, Alice L. Walton School of Medicine, Bentonville, AR, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Singh, O., Dampier, C., Abdullaev, Z., Dazelle, K., Chung, H. J., Conway, K., Camelo-Piragua, S., Neill, S., Brown, D., Nix, J. S., Giannini, C., Macaulay, R., Marker, D., Skaugen, J., Kulich, S., Lee, H., Aboud, O., Pytel, P., Borys, E., …, & Nasrallah, M. P. (2025). Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients. Acta Neuropathologica. https://doi.org/10.1007/s00401-025-02873-8
Vancouver
Singh O, Dampier C, Abdullaev Z, Dazelle K, Chung HJ, Conway K, et al. Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02873-8
BibTeX
@article{Singh2025,
author = {Singh, Omkar and Dampier, Christopher and Abdullaev, Zied and Dazelle, Karen and Chung, Hye-Jung and Conway, Kyle and Camelo-Piragua, Sandra and Neill, Stewart and Brown, Daniel and Nix, James Stephen and Giannini, Caterina and Macaulay, Robert and Marker, Daniel and Skaugen, John and Kulich, Scott and Lee, Han and Aboud, Orwa and Pytel, Peter and Borys, Ewa and Perry, Arie and Naqib-Osman, Laila and Fernandes, Igor Lima and Mao, Qinwen and Alashari, Mouied and Thomas, Cheddhi and Helgager, Jeffrey and Gubbiotti, Maria A and Newman, John and Tiwari, Nishant and Cimino, Patrick J and Quezado, Martha and Aldape, Kenneth D and Nasrallah, MacLean P},
title = {Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients},
journal = {Acta Neuropathologica},
year = {2025},
doi = {10.1007/s00401-025-02873-8}
}
EUVIMED